XLS Share Price Performance
CHF 16.50
-6.70 (-28.88%)
Price CHF 16.50
Share Pricen/a
Xlife Sciences AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
XLS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Xlife Sciences AG Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 24, 2026
- -3.78
- 3.38%
- -7,826.51%
- 16.1%
About XLS
- Founded
- 2019
- Employees
- 20
- CEO
- WebsiteView website
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data; and offers clinical research services. It also develops novel treatment options in specific indication areas; focuses in the areas of medical technology to develop innovative methods for diagnosing illnesses and/or patient monitoring; and deploys artificial intelligence to improve diagnostic methods and/or processes in the field of biotechnology. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.
